Catalog entryPeptide blend- Tissue Repair

KLOW Blend

KLOW Blend is a proprietary multi-peptide blend commonly listed as GHK-Cu, BPC-157, TB-500, and KPV in a total 80 mg vial. It is marketed in research and wellness circles for tissue repair, skin remodeling, and inflammation-related support, but it is not an FDA-approved drug, and the blend itself does not have an established standardized clinical evidence base as a single product.

Overview

Public product listings consistently describe KLOW as a four-component blend intended to combine connective-tissue repair, dermal remodeling, collagen support, and anti-inflammatory signaling into one vial. The most consistently repeated composition is GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg + KPV 10 mg. These descriptions come from commercial research-supply listings, not from an official drug monograph or approved prescribing source

What it is

KLOW Blend is a proprietary peptide blend, not a single peptide. Based on current listings, it appears to include: GHK-Cu — copper peptide BPC-157 — investigational pentadecapeptide TB-500 — thymosin beta-4 fragment analogue / research peptide KPV — tripeptide associated with anti-inflammatory research

Mechanism (high level)

As marketed, KLOW is intended to combine several distinct research pathways: collagen and dermal remodeling from GHK-Cu, soft-tissue and gut-repair signaling from BPC-157, cell migration / tissue repair biology from TB-500, and anti-inflammatory signaling from KPV. That said, these mechanisms are inferred from the individual components, not from robust clinical trials of the KLOW blend itself.

Quick facts

Dosage
No standardized evidence-based human dose is established for KLOW Blend as a blend.
Route
Route depends on source and protocol; no approved standardized route established for the blend itself.
Cycle
No standardized cycle established.
Storage
Follow supplier or pharmacy instructions exactly Protect from heat and light Store only as labeled by the dispensing source Do not assume all KLOW products use identical formulation or handling Because this is a proprietary non-standardized blend, storage should be tied to the actual dispensed product rather than a generic universal rule.

Research indications

  • Tissue repair research
  • Skin remodeling research
  • Collagen-support research
  • Soft-tissue recovery research
  • Inflammation-modulation research
  • Dermal biology research
  • Connective-tissue support research
  • Localized recovery research

Interactions

Often avoided with

  • Unverified or unlabeled proprietary blend sources
  • Use outside clinician supervision
  • Pregnancy unless clinician supervised
  • Breastfeeding unless clinician supervised
  • Use when relying on proven treatment for serious injury or inflammatory disease
  • Use in competitive sport if any component creates anti-doping concern

Often combined with

  • Clinician-supervised investigational discussion
  • Review of individual peptide component research
  • Use only with verified labeling and sourcing
  • Research-oriented tissue-repair catalog context
  • Since KLOW is a proprietary blend, the safest interaction framing is based on uncertainty, source verification, and non-approval status, rather than pretending there is a formal interaction database for the blend itself. The public listings themselves also repeatedly describe it as research-only or laboratory material.

KLOW Blend is not a single standardized approved peptide. Publicly available descriptions indicate it is a proprietary multi-peptide blend, most often listed as GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg, and KPV 10 mg per 80 mg vial. Use conservative language and avoid presenting the blend as having an established approved therapeutic indication.

Side effects & safety

  • No standardized human safety profile established for the blend
  • Product quality and composition may vary by source
  • Potential risk from proprietary multi-component formulation
  • Potential contamination or impurity risk from non-verified supply
  • Long-term safety of the blend is not established
  • Blend-specific clinical safety data are limited or not identified

Regulatory notes

  • Not an FDA-approved drug
  • Proprietary peptide blend rather than a single defined approved compound
  • Publicly sold mainly as research-only or laboratory material
  • No standardized approved labeling identified for KLOW Blend
  • Blend claims should be framed as investigational only

FAQ

What is KLOW Blend?

KLOW Blend is a proprietary peptide blend commonly listed as GHK-Cu, BPC-157, TB-500, and KPV

What is in KLOW Blend?

The most consistently listed composition is GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg, and KPV 10 mg.

Is KLOW Blend FDA approved?

No approved FDA drug labeling for KLOW Blend was identified. Public listings describe it as a proprietary research-only blend.

What is KLOW Blend used for?

It is commonly marketed for research into tissue repair, skin remodeling, collagen support, and inflammation-related recovery, but these are investigational positioning claims rather than approved indications.

Track in app

Save favorites, compare protocols, and track over time

PepTok gives you structure: stacks, reminders, notes, and progress snapshots in one place.

Download iOSDownload Android

Educational content only. This material is not medical advice. Verify legality, sourcing, and dosing with a qualified professional.